Research Article| Volume 147, ISSUE 1, P78-82, November 2009

Age-specific differences in the treatment of cervical cancer in the east and the south of The Netherlands 1989–2004



      This study aims to describe trends and variation in treatment and survival of cervical cancer in two regions in The Netherlands and to relate this to adherence to the treatment recommendations.

      Study design

      Patient characteristics, tumour characteristics, treatment and follow-up data were collected for 1954 cervical cancer cases diagnosed in the period 1989–2004.


      In FIGO stages IB-IIA 93% of patients were treated according to the recommendations of The Netherlands Working Group Gynaecologic Oncology. Older patients received radiotherapy more often than younger patients: 48% (95%CI 40–57) of patients older than 70 compared to 15% (95%CI 10–20) of patients aged 50–69 and 5% (95%CI 3–7) of patients aged 50 or younger (p < 0.05). In FIGO stages IIB-IVA 76% of patients were treated according to the recommendations of the Working Group. Chemoradiation was given to older patients less often than to younger patients: 2% (95%CI 0.5–5) versus 23% (95%CI 16–29). A decreased risk of death was found for patients receiving chemoradiation (RER 0.6, 95%CI 0.3–0.9) compared to those receiving “radiotherapy only”.


      Far from being always followed, the treatment recommendations were better implemented for treatment of patients with FIGO IB-IIA. Elderly patients received different treatment compared to younger patients in this study and showed an independent increased risk of death in the lower stages, which confirms that the need becomes stronger for paying attention to treatment of elderly patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Yamashita H.
        • Nakagawa K.
        • Tago M.
        • et al.
        Comparison between conventional surgery and radiotherapy for FIGO stage I–II cervical carcinoma: a retrospective Japanese study.
        Gynecol Oncol. 2005; 97: 834-839
        • van der Velden J.
        • Samlal R.
        • Schilthuis M.S.
        • Gonzalez D.G.
        • ten Kate F.J.
        • Lammes F.B.
        A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi radical hysterectomy for cervical cancer confined to the cervix.
        Gynecol Oncol. 1999; 75: 233-237
        • Trimbos J.B.
        Gynaecologische Oncologieklapper.
        2nd ed. Working Group for Gynecological Oncology, Leiden, The Netherlands1995
      1. Work Group Oncologic Gynaecology.

        • Ryu H.S.
        • Chun M.
        • Chang K.H.
        • Chang H.J.
        • Lee J.P.
        Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
        Gynecol Oncol. 2005; 96: 490-495
        • Rose P.G.
        • Bundy B.N.
        • Watkins E.B.
        • et al.
        Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
        N Engl J Med. 1999; 340: 1144-1153
        • Morris M.
        • Eifel P.J.
        • Lu J.
        • et al.
        Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
        N Engl J Med. 1999; 340: 1137-1143
        • Whitney C.W.
        • Sause W.
        • Bundy B.N.
        • et al.
        Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
        J Clin Oncol. 1999; 17: 1339-1348
        • Keys H.M.
        • Bundy B.N.
        • Stehman F.B.
        • et al.
        Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
        N Engl J Med. 1999; 340: 1154-1161
        • Peters III, W.A.
        • Liu P.Y.
        • Barrett R.J.
        • et al.
        Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.
        J Clin Oncol. 2000; 18: 1606-1613
        • van der Zee J.
        • Gonzalez G.D.
        The Dutch Deep Hyperthermia Trial: results in cervical cancer.
        Int J Hyperthermia. 2002; 18: 1-12
        • Hanselaar A.G.
        Criteria for organized cervical screening programs special emphasis on The Netherlands program.
        Acta Cytol. 2002; 46: 619-629
      2. Ederer F, Heise H. Instructions to IBM 6500 programmers in processing survival computations. Methodological note no. 10, End Results Evaluation Section. Bethesda MD: National Cancer Institute; 1959.

        • Abayomi J.
        • Kirwan J.
        • Hackett A.
        • Bagnall G.
        A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer.
        J Hum Nutr Diet. 2005; 18: 353-363
        • Hawighorst-Knapstein S.
        • Fusshoeller C.
        • Franz C.
        • et al.
        The impact of treatment for genital cancer on quality of life and body image—results of a prospective longitudinal 10-year study.
        Gynecol Oncol. 2004; 94: 398-403
        • Jensen P.T.
        • Groenvold M.
        • Klee M.C.
        • Thranov I.
        • Petersen M.A.
        • Machin D.
        Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer.
        Int J Radiat Oncol Biol Phys. 2003; 56: 937-949
        • Schouten L.J.
        • Langendijk J.A.
        • Jager J.J.
        • van den Brandt P.A.
        Validity of the stage of lung cancer in records of the Maastricht cancer registry, The Netherlands.
        Lung Cancer. 1997; 17: 115-122
        • Green J.A.
        • Kirwan J.M.
        • Tierney J.F.
        • et al.
        Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.
        Lancet. 2001; 358: 781-786
        • Goodheart M.
        • Jacobson G.
        • Smith B.J.
        • Zhou L.
        Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity.
        Int J Gynecol Cancer. 2007;
        • Wright J.D.
        • Gibb R.K.
        • Geevarghese S.
        • et al.
        Cervical carcinoma in the elderly: an analysis of patterns of care and outcome.
        Cancer. 2005; 103: 85-91
        • Yellen S.B.
        • Cella D.F.
        • Leslie W.T.
        Age and clinical decision making in oncology patients.
        J Natl Cancer Inst. 1994; 86: 1766-1770
        • Newcomb P.A.
        • Carbone P.P.
        Cancer treatment and age: patient perspectives.
        J Natl Cancer Inst. 1993; 85: 1580-1584
      3. Signaleringscommissie Kanker van KWF Kankerbestrijding. Kanker in Nederland; Trends, prognoses en implicaties voor zorgvraag. Oisterwijk: Drukkerij van den Boogaard; 2004.